Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
12.48
0.00 (0.00%)
May 15, 2026, 9:44 AM CST
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 397.82M CNY in the quarter ending March 31, 2026, a decrease of -4.78%. This brings the company's revenue in the last twelve months to 1.79B, down -10.38% year-over-year. In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B, down -9.99%.
Revenue (ttm)
1.79B
Revenue Growth
-10.38%
P/S Ratio
3.98
Revenue / Employee
1.07M
Employees
1,678
Market Cap
7.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -200.99M | -9.99% |
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.68B |
| Sinocare | 4.86B |
| Wuhan Huakang Century Clean Technology | 2.40B |
| Edan Instruments | 2.09B |
| INKON Life Technology | 1.97B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.87B |
| Beijing Wandong Medical Technology | 1.38B |
| Sino Medical Sciences Technology | 564.29M |